Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

Completed · Phase 2

Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy following surgery in treating patients who have urinary tract cancer.

Key facts

Study ID

NCT00028860

Run by

Tulane University Health Sciences Center

Starts

2001-10-01

Expected to finish

2004-10-01

Last updated by the study team

2013-07-10

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Tulane Cancer Center at Tulane University Hospital and Clinic — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.